前列腺癌神经内分泌分化中的分子影像:68Ga-PSMA与68Ga-DOTA NOC PET-CT对比
Molecular Imaging in Neuroendocrine Differentiation of Prostate Cancer: 68Ga-PSMA Versus 68Ga-DOTA NOC PET-CT.
PubMed 文献 · Clin Nucl Med · 2017-01-01
报告1例2011年确诊的62岁转移性前列腺癌(cT3b N1)患者,经氟他胺和醋酸戈舍瑞林全雄激素阻断治疗后无症状5年,出现左肩胛上区肿胀和腰背痛,PSA 0.049 ng/mL。
要点
- 前列腺癌去势治疗后PSA极低时出现新发症状,需警惕神经内分泌分化。
- 68Ga-DOTA NOC PET-CT有助于识别前列腺癌神经内分泌分化所致PSMA阴性转移。
研究设计与样本
- 病例报告:1例62岁男性转移性前列腺癌(cT3b N1)患者,2011年确诊,接受氟他胺和醋酸戈舍瑞林全雄激素阻断治疗。
主要发现
- 患者无症状5年后出现左肩胛上区肿胀和腰背痛,前列腺特异性抗原为0.049 ng/mL。
- 68Ga-DOTA NOC扫描在10天后进行,显示多发生长抑素亲和性肝及淋巴结转移。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We report on a 62-year-old man with metastatic prostate cancer (cT3b N1) diagnosed in 2011, treated with total androgen blockage with flutamide and goserelin acetate (Zoladex). He presented with left suprascapular swelling and low-back pain after being asymptomatic for 5 years. His prostate-specific antigen was 0.049 ng/mL. F-NaF PET-CT and Ga-PSMA scan were negative, whereas Ga-DOTA NOC scan done after 10 days showed multiple somatostatin-avid hepatic and lymph node metastasis.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Usmani S, Ahmed N, Marafi F, et al. Molecular Imaging in Neuroendocrine Differentiation of Prostate Cancer: 68Ga-PSMA Versus 68Ga-DOTA NOC PET-CT. Clin Nucl Med. 2017. PMID: 28240661. doi:10.1097/RLU.0000000000001618
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。